Jubilant Cadista Pharmaceuticals FDA Inspection Record

FEI 3017221809 · Inspections, Form 483s, warning letters and import refusals

Jubilant Cadista Pharmaceuticals is an FDA-inspected facility (FEI 3017221809) located in Yardley, PA, US. RegDataLab tracks 9 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Jan 15, 2025: Voluntary Action Indicated (VAI)
Inspections on record
9 (6 VAI, 3 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Import refusals
1

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jan 15, 2025Voluntary Action Indicated (VAI)Records not made readily available to FDA (21 CFR 211.180(c))
Signature and checking of records -- 2 persons (21 CFR 211.186(a))
Identification of Persons Performing Significant Steps (21 CFR 211.188(b)(11))
Systems in place to comply with verification requirements (FDCA 582(b)(4))
and 1 more
Feb 28, 2020Voluntary Action Indicated (VAI)Procedures for non-sterile drug products (21 CFR 211.113(a))
Applicant did not submit/submitted late 3-Day Field Alert Report or wrong format (21 CFR 514.80(b)(1))
Procedures to be written and followed (21 CFR 211.198(a))
May 4, 2018No Action Indicated (NAI)No citations listed
Aug 7, 2015Voluntary Action Indicated (VAI)Training , Education , Experience overall (21 CFR 211.25(a))
Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
SOPs not followed / documented (21 CFR 211.100(b))
Rejected Material Area (21 CFR 211.42(c)(2))
and 3 more
Jul 8, 2014No Action Indicated (NAI)No citations listed
Aug 1, 2013No Action Indicated (NAI)No citations listed
Apr 5, 2012Voluntary Action Indicated (VAI)No citations listed
Mar 23, 2011Voluntary Action Indicated (VAI)Failing drug products not rejected (21 CFR 211.165(f))
Written program not followed (21 CFR 211.166(a))
Investigations of discrepancies, failures (21 CFR 211.192)
Oct 29, 2009Voluntary Action Indicated (VAI)No citations listed

FDA record score

8 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

6 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIJan 15, 20256 x 16
Inspection classified VAIFeb 28, 20206 x 0.251.5
Inspection classified VAIAug 7, 201510 years or older, so it adds no points0
Inspection classified VAIApr 5, 201210 years or older, so it adds no points0
Inspection classified VAIMar 23, 201110 years or older, so it adds no points0
Inspection classified VAIOct 29, 200910 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Jubilant Cadista Pharmaceuticals as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Jubilant Cadista Pharmaceuticals yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Jubilant Cadista Pharmaceuticals
Location
Yardley, PA (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.